About CelLBxHealth

CelLBxHealth specialises in circulating tumour cell intelligence for cancer research and diagnostics. The Parsortix platform uses patented microfluidics to capture intact CTCs from whole blood, enabling downstream analysis. This minimally invasive approach provides researchers and pharmaceutical companies with repeatable access to cancer biomarkers without tissue biopsies. The platform serves biopharmaceutical companies, translational researchers and clinical laboratories worldwide. CelLBxHealth combines product solutions with GCP compliant laboratory services. This dual approach accelerates drug development, supports personalised medicine and advances patient care through accessible, repeatable cancer diagnostics.